To include your compound in the COVID-19 Resource Center, submit it here.

ALLP suspends Phase III cardiac study

Alliance Pharmaceutical (ALLP) said it voluntarily suspended enrollment in a Phase III study of its Oxygent perflubron blood

Read the full 182 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE